Wu et al. reported that treatment with 10 μM rifampicin could significantly inhibit rotenone-induced cell apoptosis via activation of the PI3K/Akt pathway [48], and systemic treatment with rifampicin was neuroprotective in a murine PD model [49]. This evidence concerns the gene AKT1 and Parkinson disease.